Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/12/2008CN100431609C Long circulation liposome with modified integrin and carried anticancer medicine for injection
11/12/2008CN100431607C Medicinal composition for tumor body
11/12/2008CN100431606C Anti-cancer medicine composition
11/12/2008CN100431605C Anticarcinogen composition
11/12/2008CN100431582C Extraction process of aloe gel concentrate
11/12/2008CN100431567C Use of delphinium glabra plant for preparing drug for stopping pain, hemostasis and anticancer
11/12/2008CN100431557C Medicine for treating and preventing tumour, and its prepn. method
11/12/2008CN100431538C An anticancer pharmaceutical composition and preparation method thereof
11/12/2008CN100431533C Medicinal composition containing backuchiol for treating female osteoporosis
11/12/2008CN100431525C Production method of liposome suspended liquid and products thereof
11/11/2008US7449559 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
11/11/2008US7449537 Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc.
11/11/2008US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones
11/11/2008US7449482 Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
11/11/2008US7449470 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide
11/11/2008US7449466 Cyclic aminophenyl sulfamate derivative
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/11/2008US7449315 Bifunctional energy-reversible acyl-compositions
11/11/2008US7449301 Pharmaceutical composition and method for activating macrophage using the same
11/11/2008US7449197 Liposome formulation of 6,9-bis[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate
11/11/2008US7449181 Remedies for cancer
11/06/2008WO2008134630A1 Dexrazoxane compounds for cardioprotection
11/06/2008WO2008134553A1 Methods of using bicyclic compounds in treating sodium channel-mediated diseases
11/06/2008WO2008134474A2 Compositions and methods including cell death inducers and procaspase activation
11/06/2008WO2008134265A2 Iminosugar for treatment of tumors
11/06/2008WO2008134088A1 Hydroxy sulfonate of quinone compounds and their uses
11/06/2008WO2008134020A1 Ccl18 and ccl3 methods and compositions for detecting and treating cancer
11/06/2008WO2008133955A1 6-phenylpyrimidinones as pim modulators
11/06/2008WO2008133866A1 Polymorph of dihydropyrazolopyrimidinone derivative as weel kinase.inhibitor
11/06/2008WO2008133789A2 Methods and compositions for targeting afap
11/06/2008WO2008133709A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/06/2008WO2008133684A1 Antibodies that bind both il-17a and il-17f and methods of using the same
11/06/2008WO2008133664A2 Carboranylporphyrins and uses thereof
11/06/2008WO2008133422A1 Method for the preparation of biocompatible polymeric nanoparticles for drug delivery and nanoparticles prepared thereby
11/06/2008WO2008133349A1 Agent for prevention of cirrhosis/precancerous lesion comprising natriuretic peptide as active ingredient
11/06/2008WO2008133292A1 Disease-related protein for scirrhous cancer
11/06/2008WO2008133192A1 Fused imidazole compound and use thereof
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133127A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008132738A2 Anticancerous polymeric agents
11/06/2008WO2008132729A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/06/2008WO2008132709A1 Products for altering il-33 activity and methods therefor
11/06/2008WO2008132568A2 Fusion proteins binding to growth factors
11/06/2008WO2008132541A2 Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
11/06/2008WO2008132505A1 N' - (phenyl) -n- (morpholin-4-yl-pyridin-2-yl) -pyrimidine-2, 4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions
11/06/2008WO2008132502A1 Pyrazolyl-amino-substituted pyrimidines and their use for the treatment of cancer
11/06/2008WO2008132500A2 Chkl inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies
11/06/2008WO2008132453A1 Antibodies against ramp3
11/06/2008WO2008132443A1 Use of sapacitabine to treat proliferative disease
11/06/2008WO2008132211A1 Amino-quinazolinone derivatives for use as radiotracers and imaging agents
11/06/2008WO2008132138A1 Derivatives of 4,6-disubstituted aminopyrimidines
11/06/2008WO2008132121A1 Lh-indazole-3-amine compounds as ikk1 inhibitors
11/06/2008WO2008131940A2 Combination of immunological agent and sensitizing agent for the treatment of cancer
11/06/2008WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008WO2008131547A1 'triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives'
11/06/2008WO2008113756A8 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
11/06/2008WO2008112498A3 Synthesis and characterization of polymorph form ii of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
11/06/2008WO2008109740A3 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
11/06/2008WO2008109361B1 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
11/06/2008WO2008098208A3 Gnaq mutations in melanoma
11/06/2008WO2008094708A3 Activin-actriia antagonists and uses for treating or preventing breast cancer
11/06/2008WO2008090565B1 Novel thermodynamically stable polymorphic form-l of letrozole
11/06/2008WO2008079291A3 Substituted heterocycles and methods of use
11/06/2008WO2008073395A3 Compositions and methods for cardiac tissue protection and regeneration
11/06/2008WO2008067351A3 Method of diagnosing and treating glioma
11/06/2008WO2008067305A3 Polypeptides comprising intracytoplasmic death domain and nkg2d ligand domain
11/06/2008WO2008024977A3 Isoquinoline, quinazoline and phthalazine derivatives
11/06/2008WO2007147644A3 Phosphate diester amides
11/06/2008WO2007110068A3 Novel isooxazole derivatives and their uses
11/06/2008WO2007101063A3 Treatment of development-related disorders
11/06/2008WO2007098474A8 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists
11/06/2008US20080275235 Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275217 Filamin A interacting protein 1 for use in directed destruction of actin binding protein filamin-1; treating neurodegenerative disorders
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275106 Anticancer and Antiprotozoal Dihydroartemisinene and Dihydroartemisitene Dimers with Desirable Chemical Functionalities
11/06/2008US20080275101 Citrate and phosphate salts of 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide for treatment of protein kinase related disorders; crystallization; pharmacokinetics
11/06/2008US20080275077 Pharmaceutical formulations comprising an immune response modifier
11/06/2008US20080275072 Weekly administration of dipeptidyl peptidase inhibitors
11/06/2008US20080275071 Radiotherapy Enhancer
11/06/2008US20080275063 C-{4-[6-(2-Ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-propyl-methanesulfonamide; antiinflammatories, antiproliferatives, analgesics; cardiovascular disorders, neurodegenerative diseases; immunotherapy
11/06/2008US20080275060 N-Hydroxyamide Derivatives and Use Thereof
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275057 Cell cycle G2-checkpoint-abrogating 1-[(2-pyridyl)amino]-azoline-2,5-dione derivatives with at least one halogen group, to selectively sensitize cancer cells to DNA damaging reagents without additional anticarcinogenic treatment; cytolytic agents, antiproliferatives, apoptosis
11/06/2008US20080275055 4-(4-methyl-piperazin-1-ylmethyl-benzoic acid with N-(5- amino-2-methylphenyl)-4-(3pyridyl)-2-pyrimidine-amine in the presence of a coupling reagent such as 2-(5-norborene-2,3- dicarboximido)- 1,1,3,3-tetramethyluronium tetrafluoroborate to produce imatinib, salt formation wtih methanesululfonic acid
11/06/2008US20080275054 3-(Substituted Amino)-Pyrazolo[3, 4-D]Pyrimidines as Ephb and Vegfr2 Kinase Inhibitors
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275039 Geldanamycin Derivatives and the Method for Biosynthesis Thereof
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
1 ... 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 ... 2211